Top

Category: News


News

MHRA Awards ‘Innovation Passport’ to CellResearch for Stem Cell Therapy

October 14, 2021

Via: Biopharm International

The Medicines and Healthcare products Regulatory Agency (MHRA)—regulatory body of the United Kingdom—has awarded an ‘Innovation Passport’ to CellResearch, a Singaporean biotech, for CorLiCyte—an umbilical cord lining stem cell therapy. CorLiCyte has been awarded the Innovation Passport through MHRA’s Innovation […]


News

Boston biotech backers quit Dana-Farber board after U-turn on investment policy: report

October 12, 2021

Via: FierceBiotech

The Dana-Farber Cancer Institute has reportedly barred trustees from newly investing in biotechs created to license its science, leading to the resignation of board members including a co-founder of C4 Therapeutics. Under the old policy, trustees could invest in startups […]


News

Senate to cull Biden’s biomedical research agency from social care bill: Report

October 11, 2021

Via: FierceBiotech

President Joe Biden’s $3 billion Advanced Research Projects Agency for Health is in jeopardy as the Senate is set to cut the agency from its social care spending bill. This is according to sources talking to Politico over the weekend […]


News

Merck makes beeline to FDA, seeking approval for COVID-19 antiviral 10 days after reporting data

October 11, 2021

Via: FierceBiotech

Merck isn’t hanging around. Ten days after reporting data on its oral COVID-19 antiviral molnupiravir, Merck has filed for emergency use authorization from the FDA as part of a rapid global push to get the drug to patients. Oct. 1, […]


News

Amid ‘reshoring’ efforts, central Virginia looks to bolster drug supply strength

October 7, 2021

Via: FiercePharma

Efforts to “reshore” drug manufacturing and address supply shortages in the U.S. have trickled down to central Virginia, where public and private partners have pledged $2.5 million in seed money for an industry accelerator. Activation Capital is launching the cluster […]


News

Bayer pledges $464M to upgrade, build production facilities in contraceptives push

October 5, 2021

Via: FiercePharma

Bayer added more punch to its global commitment to get 100 million women and girls improved access to contraceptives by the end of the decade by pledging $464 million (€400 million) toward upgrading and building manufacturing facilities. The investment is […]


News

Novel Approach for Intravenous Cancer Immunotherapy

October 1, 2021

Via: Genetic Engineering and Biotechnology News

Researchers at the University of Michigan (U-M) School of Pharmacy and the Rogel Cancer Center took a different approach to boosting the STING pathway. The team observed that adding the nutritional metal ion manganese to STING agonists boosted STING’s tumor-fighting […]


News

YonaLink, TrialJectory get $1m grant for patient recruitment tool

September 27, 2021

Via: Pharmaphorum

The grant from the Israel-US Binational Industrial Research and Development (BIRD) Foundation will go towards the further development of the platform, which automates the conduct of trials in a bid to reduce the cost, time, and resources used running them. […]


News

Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight

September 24, 2021

Via: FiercePharma

Even before Merck and Pfizer won back-to-back FDA nods for their rival pneumococcal conjugate vaccines this summer, the companies were fighting it out in court over patents on the lucrative shots. With a new settlement, the pharma rivals are putting […]


News

After Clinical Setbacks, Theravance Axes 75% of Workforce and Refocuses on Respiratory Drugs

September 16, 2021

Via: Genetic Engineering and Biotechnology News

Intent on bouncing back from a pair of later-phase clinical trial failures, Theravance Biopharma said it will eliminate about 75% of its workforce—270 jobs—and slash its R&D budget next year through a restructuring that will refocus the company on respiratory […]


News

After criticism, Johnson & Johnson COVID-19 vaccines shipped from South Africa to Europe to be returned

September 2, 2021

Via: FiercePharma

Johnson & Johnson drew sharp criticism two weeks ago amid reports that doses of its single-shot COVID-19 vaccine produced in South Africa were being exported to Europe. Now, it appears that the arrangement is coming to an end. J&J doses […]


News

Sesen, still reeling from FDA rejection, pulls filing for EU approval of cancer drug

August 26, 2021

Via: FierceBiotech

The rapid unraveling of Sesen Bio goes on. Two weeks ago, the biotech was on the cusp of winning FDA approval for cancer drug Vicineum and working its way toward authorization in Europe. Now, with the FDA rejecting Vicineum days […]